These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 32524558)

  • 1. Isolation of Cerebral Endothelial Cells from CCM1/KRIT1 Null Mouse Brain.
    Nobiletti N; Glading AJ
    Methods Mol Biol; 2020; 2152():259-265. PubMed ID: 32524558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production of KRIT1-knockout and KRIT1-knockin Mouse Embryonic Fibroblasts as Cellular Models of CCM Disease.
    Goitre L; Fornelli C; Zotta A; Perrelli A; Retta SF
    Methods Mol Biol; 2020; 2152():151-167. PubMed ID: 32524551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of CCM Phenotype by a Human Microvascular Endothelial Model.
    Delle Monache S; Retta SF
    Methods Mol Biol; 2020; 2152():131-137. PubMed ID: 32524549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KRIT1 loss-of-function induces a chronic Nrf2-mediated adaptive homeostasis that sensitizes cells to oxidative stress: Implication for Cerebral Cavernous Malformation disease.
    Antognelli C; Trapani E; Delle Monache S; Perrelli A; Daga M; Pizzimenti S; Barrera G; Cassoni P; Angelucci A; Trabalzini L; Talesa VN; Goitre L; Retta SF
    Free Radic Biol Med; 2018 Feb; 115():202-218. PubMed ID: 29170092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel mouse model of cerebral cavernous malformations based on the two-hit mutation hypothesis recapitulates the human disease.
    McDonald DA; Shenkar R; Shi C; Stockton RA; Akers AL; Kucherlapati MH; Kucherlapati R; Brainer J; Ginsberg MH; Awad IA; Marchuk DA
    Hum Mol Genet; 2011 Jan; 20(2):211-22. PubMed ID: 20940147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KLF4 is a key determinant in the development and progression of cerebral cavernous malformations.
    Cuttano R; Rudini N; Bravi L; Corada M; Giampietro C; Papa E; Morini MF; Maddaluno L; Baeyens N; Adams RH; Jain MK; Owens GK; Schwartz M; Lampugnani MG; Dejana E
    EMBO Mol Med; 2016 Jan; 8(1):6-24. PubMed ID: 26612856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation and Purification of Mouse Brain Endothelial Cells to Study Cerebral Cavernous Malformation Disease.
    Hale P; Soliman SI; Sun H; Lopez-Ramirez MA
    Methods Mol Biol; 2020; 2152():139-150. PubMed ID: 32524550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombospondin1 (TSP1) replacement prevents cerebral cavernous malformations.
    Lopez-Ramirez MA; Fonseca G; Zeineddine HA; Girard R; Moore T; Pham A; Cao Y; Shenkar R; de Kreuk BJ; Lagarrigue F; Lawler J; Glass CK; Awad IA; Ginsberg MH
    J Exp Med; 2017 Nov; 214(11):3331-3346. PubMed ID: 28970240
    [No Abstract]   [Full Text] [Related]  

  • 9. Study of CCM Microvascular Endothelial Phenotype by an In Vitro Tubule Differentiation Model.
    Delle Monache S; Retta SF
    Methods Mol Biol; 2020; 2152():371-375. PubMed ID: 32524565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postzygotic mosaicism in cerebral cavernous malformation.
    Rath M; Pagenstecher A; Hoischen A; Felbor U
    J Med Genet; 2020 Mar; 57(3):212-216. PubMed ID: 31446422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of Cerebral Cavernous Malformation in Neonatal Mouse Models Using Inducible Cre-LoxP Strategy.
    Choi JP; Zheng X
    Methods Mol Biol; 2020; 2152():253-258. PubMed ID: 32524557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel CCM1 (KRIT1) Mutation Detection in Brazilian Familial Cerebral Cavernous Malformation: Different Genetic Variants in Inflammation, Oxidative Stress, and Drug Metabolism Genes Affect Disease Aggressiveness.
    Fontes-Dantas FL; da Fontoura Galvão G; Veloso da Silva E; Alves-Leon S; Cecília da Silva Rêgo C; Garcia DG; Marques SA; Blanco Martinez AM; Reis da Silva M; Marcondes de Souza J
    World Neurosurg; 2020 Jun; 138():535-540.e8. PubMed ID: 32113992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KRIT1: A Traffic Warden at the Busy Crossroads Between Redox Signaling and the Pathogenesis of Cerebral Cavernous Malformation Disease.
    Perrelli A; Ferraris C; Berni E; Glading AJ; Retta SF
    Antioxid Redox Signal; 2023 Mar; 38(7-9):496-528. PubMed ID: 36047808
    [No Abstract]   [Full Text] [Related]  

  • 14. Vertebrate Models to Investigate CCM Pathogenesis: The Zebrafish and Mouse Model.
    Abou-Fadel J; Zhang J
    Methods Mol Biol; 2020; 2152():225-251. PubMed ID: 32524556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of CCM1 induces hypersprouting and impairs response to flow.
    Mleynek TM; Chan AC; Redd M; Gibson CC; Davis CT; Shi DS; Chen T; Carter KL; Ling J; Blanco R; Gerhardt H; Whitehead K; Li DY
    Hum Mol Genet; 2014 Dec; 23(23):6223-34. PubMed ID: 24990152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From Genes and Mechanisms to Molecular-Targeted Therapies: The Long Climb to the Cure of Cerebral Cavernous Malformation (CCM) Disease.
    Retta SF; Perrelli A; Trabalzini L; Finetti F
    Methods Mol Biol; 2020; 2152():3-25. PubMed ID: 32524540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rho kinase inhibition rescues the endothelial cell cerebral cavernous malformation phenotype.
    Borikova AL; Dibble CF; Sciaky N; Welch CM; Abell AN; Bencharit S; Johnson GL
    J Biol Chem; 2010 Apr; 285(16):11760-4. PubMed ID: 20181950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Caveolae-mediated Tie2 signaling contributes to CCM pathogenesis in a brain endothelial cell-specific Pdcd10-deficient mouse model.
    Zhou HJ; Qin L; Jiang Q; Murray KN; Zhang H; Li B; Lin Q; Graham M; Liu X; Grutzendler J; Min W
    Nat Commun; 2021 Jan; 12(1):504. PubMed ID: 33495460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebral cavernous malformation protein CCM1 inhibits sprouting angiogenesis by activating DELTA-NOTCH signaling.
    Wüstehube J; Bartol A; Liebler SS; Brütsch R; Zhu Y; Felbor U; Sure U; Augustin HG; Fischer A
    Proc Natl Acad Sci U S A; 2010 Jul; 107(28):12640-5. PubMed ID: 20616044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Precise CCM1 gene correction and inactivation in patient-derived endothelial cells: Modeling Knudson's two-hit hypothesis in vitro.
    Spiegler S; Rath M; Much CD; Sendtner BS; Felbor U
    Mol Genet Genomic Med; 2019 Jul; 7(7):e00755. PubMed ID: 31124307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.